Somatic gene therapy for human disease: background and prospects. Part II.
D000243:Adenosine Deaminase / Q000172:deficiency; D001778:Blood Coagulation Disorders / Q000628:therapy; D005818:Genetic Engineering; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D007154:Immune System Diseases / Q000628:therapy; D008107:Liver Diseases / Q000628:therapy; D008661:Metabolism, Inborn Errors / Q000628:therapy; D010661:Phenylketonurias / Q000628:therapy; D011683:Purine-Nucleoside Phosphorylase / Q000172:deficiency; D013789:Thalassemia / Q000628:therapy
D011683:Purine-Nucleoside Phosphorylase; D000243:Adenosine Deaminase